StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
Publishing Date
2023 - 09 - 09
1
2023 - 02 - 02
1
2023 - 01 - 27
1
2022 - 05 - 30
1
2022 - 04 - 13
1
2022 - 03 - 15
1
2021 - 06 - 01
1
2021 - 03 - 16
1
Sector
Health technology
8
Tags
Abbvie
77
Active
14
Aesthetic
22
Alliances
19
America
42
Antibody
17
Application
15
Approval
37
Atopic dermatitis
10
Biomidwest
43
Biotech-beach
10
Business
12
Cancer
53
Cd20
13
Chmp
10
Clinical-trials-phase-iii
25
Collaboration
23
Conference
32
Contract
13
Deadline
11
Dermatitis
14
Disease
65
Drug
75
Duobody
13
Earnings
22
Europe
16
Events
24
Expected
18
Eye
17
Fda
42
Financial
26
Financial results
12
Genetown
11
Global
113
Growing
24
Growth
174
Health
20
Leukemia
16
Market
383
Meeting
12
Migraine
23
N/a
783
Pharma
17
Pharmaceuticals
11
Phase 3
30
Positive
30
Reach
16
Report
97
Research
81
Results
79
Rinvoq
27
Risankizumab
14
Set
15
Skyrizi
16
Therapeutics
88
Therapy
40
Treatment
117
Trial
32
Ulcerative colitis
14
Year
12
Entities
Abbvie inc.
8
Bristol-myers squibb company
6
Gilead sciences, inc.
4
Glaxosmithkline plc
5
Johnson & johnson
6
Novartis ag
2
Sanofi
1
Teva pharmaceutical industries ltd
1
Tonix pharmaceuticals holding corp.
1
Viatris inc.
2
Vir biotechnology, inc.
1
Symbols
ABBV
8
ABT
2
ABUS
2
ADMP
1
ADTX
5
ALDX
1
ALGS
1
AVIR
5
AYTU
1
BIXT
4
BMY
7
CDTX
1
CMRX
3
COCP
32
EBS
2
ENTA
4
FNCTF
5
GILD
12
GLAXF
5
GSK
6
IGMS
1
IMRN
1
IPIX
2
JNJ
16
LEXX
4
LLY
4
MOLN
1
MRK
14
MTNB
1
NNVC
9
NOVN
2
NVO
1
NVS
3
NVSEF
2
PFE
10
PHIO
1
PVCT
1
RDY
3
RPM
1
SINT
1
SNY
3
SNYNF
3
TAK
1
TEVJF
1
TG
1
TNXP
11
TOMDF
4
TWST
1
VERA
1
VERU
1
VIR
1
VIRI
4
VTRS
2
VXRT
1
Exchanges
Nasdaq
6
Nyse
8
Crawled Date
2023 - 09 - 09
1
2023 - 02 - 02
1
2023 - 01 - 27
1
2022 - 05 - 30
1
2022 - 04 - 13
1
2022 - 03 - 15
1
2021 - 06 - 01
1
2021 - 03 - 16
1
Crawled Time
01:00
1
04:20
1
11:00
1
13:20
1
13:30
1
15:00
1
15:20
1
16:00
1
Source
www.biospace.com
1
www.prnewswire.com
7
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Antiviral
symbols :
Abbv
save search
Oral Antiviral Market Report 2023: Demand for Novel Therapeutics Boosts Opportunities
Published:
2023-09-09
(Crawled : 04:20)
- prnewswire.com
VTRS
|
$11.1
-0.18%
-0.23%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.6
-0.88%
0.03%
2.6M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$47.84
-0.87%
0.48%
9.9M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.93
-0.57%
-0.55%
3.8M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
0.65%
-14.18%
290
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
Email alert
Add to watchlist
report
antiviral
therapeutics
market
The Global Antiviral Drugs Market to Exhibit Growth at a Paltry CAGR of ~4% by 2027 | DelveInsight
Published:
2023-02-02
(Crawled : 16:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
28.31%
|
O:
-1.71%
H:
0.0%
C:
0.0%
VTRS
|
$11.1
-0.18%
-0.23%
4.7M
|
Health Technology
|
-9.46%
|
O:
-0.16%
H:
0.08%
C:
-0.41%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
5.5%
|
O:
-1.87%
H:
0.01%
C:
-0.55%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-12.22%
|
O:
-1.16%
H:
1.98%
C:
1.56%
BMY
|
$47.84
-0.87%
0.48%
9.9M
|
Health Technology
|
-32.25%
|
O:
-1.28%
H:
3.64%
C:
3.48%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
11.82%
|
O:
-0.46%
H:
0.0%
C:
-0.75%
VIR
|
$8.25
-1.32%
-1.27%
770K
|
Health Technology
|
-71.71%
|
O:
0.62%
H:
2.22%
C:
1.94%
TNXP
|
$0.1594
6.34%
5.19%
2M
|
Health Technology
|
-97.81%
|
O:
0.85%
H:
5.08%
C:
0.0%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-5.03%
|
O:
-1.44%
H:
0.0%
C:
0.0%
GILD
|
$66.93
-0.57%
-0.55%
3.8M
|
Health Technology
|
-20.32%
|
O:
-1.95%
H:
0.16%
C:
-1.18%
global
antiviral
growth
market
Global Antiviral Therapies Market Anticipated to Gather $66,016.5 Million and Grow at 3.1% CAGR in the 2020-2027 Forecast Period [208-Pages] | Details by Research Dive
Published:
2023-01-27
(Crawled : 13:20)
- prnewswire.com
GLAXF
|
$20.2
0.65%
-14.18%
290
|
Health Technology
|
16.76%
|
O:
1.13%
H:
1.57%
C:
1.57%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-14.28%
|
O:
-0.21%
H:
0.19%
C:
-0.18%
GSK
|
$39.6
-0.88%
0.03%
2.6M
|
Health Technology
|
12.05%
|
O:
-0.03%
H:
0.3%
C:
-0.08%
BMY
|
$47.84
-0.87%
0.48%
9.9M
|
Health Technology
|
-33.88%
|
O:
0.0%
H:
0.63%
C:
-0.74%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
11.21%
|
O:
-0.06%
H:
0.25%
C:
-0.7%
research
global
antiviral
market
Antiviral Drugs Market is expected to grow at a steady pace by 2027 | CAGR: 3.4% | UnivDatos Market Insights
Published:
2022-05-30
(Crawled : 15:20)
- prnewswire.com
GLAXF
|
$20.2
0.65%
-14.18%
290
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$47.84
-0.87%
0.48%
9.9M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.6
-0.88%
0.03%
2.6M
|
Health Technology
|
Email alert
Add to watchlist
antiviral
expected
market
drug
Antiviral Drugs Market Size To Reach USD 50.02 BN In 2030 Due to Development Of New, Improved, And More Advanced Formulations, Such As Repurposed Drugs And Drug Combination Therapies, Says Reports and Data
Published:
2022-04-13
(Crawled : 15:00)
- prnewswire.com
GLAXF
|
$20.2
0.65%
-14.18%
290
|
Health Technology
|
-28.97%
|
O:
1.76%
H:
0.35%
C:
0.35%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
22.54%
|
O:
0.45%
H:
0.0%
C:
-0.83%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
0.44%
|
O:
0.12%
H:
0.44%
C:
0.17%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-19.38%
|
O:
0.08%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.03%
2.6M
|
Health Technology
|
-15.35%
|
O:
-0.24%
H:
0.45%
C:
0.39%
BMY
|
$47.84
-0.87%
0.48%
9.9M
|
Health Technology
|
-36.96%
|
O:
0.24%
H:
0.53%
C:
0.18%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
-2.02%
|
O:
-1.38%
H:
0.0%
C:
-3.67%
GILD
|
$66.93
-0.57%
-0.55%
3.8M
|
Health Technology
|
8.6%
|
O:
-0.02%
H:
0.8%
C:
0.71%
drug
antiviral
repurposed
market
AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19
Published:
2022-03-15
(Crawled : 13:30)
- biospace.com/
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
7.77%
|
O:
0.11%
H:
2.74%
C:
2.38%
covid-19
treatment
research
covid
collaboration
antiviral
$ 19.89 Billion growth expected in Antiviral Drugs Market during 2021-2025 | AbbVie Inc., Bristol-Myers Squibb Co., and F. Hoffmann-La Roche Ltd. Emerge as Major Vendors | Technavio
Published:
2021-06-01
(Crawled : 01:00)
- prnewswire.com
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
44.81%
|
O:
0.44%
H:
0.26%
C:
-1.31%
antiviral
drug
growth
merge
$76.28 Billion Anti-Viral Therapies Market, 2027 - Growing Emphasis on Launching Anti-Viral Agents
Published:
2021-03-16
(Crawled : 11:00)
- prnewswire.com
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-9.76%
|
O:
0.02%
H:
0.76%
C:
0.57%
GSK
|
$39.6
-0.88%
0.03%
2.6M
|
Health Technology
|
10.37%
|
O:
0.08%
H:
1.42%
C:
1.23%
BMY
|
$47.84
-0.87%
0.48%
9.9M
|
Health Technology
|
-21.39%
|
O:
-0.08%
H:
1.3%
C:
0.91%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
48.67%
|
O:
-0.28%
H:
1.03%
C:
0.81%
GILD
|
$66.93
-0.57%
-0.55%
3.8M
|
Health Technology
|
6.12%
|
O:
0.27%
H:
1.52%
C:
1.22%
growing
therapy
antiviral
Gainers vs Losers
57%
43%
Top 10 Gainers
INVO
|
$1.82
139.47%
56.82%
220M
|
Health Technology
SINT
|
$0.0373
62.88%
37.26%
460M
|
Health Technology
WISA
4
|
$9.25
51.64%
34.27%
64M
|
Electronic Technology
EDBL
|
News
|
$6.66
46.37%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
600K
|
Manufacturing
TCON
|
$2.29
33.92%
26.61%
1.8M
|
Health Technology
TIRX
|
$0.4848
7.49%
24.58%
5.9M
|
SRFM
4
|
$0.3859
-12.3%
23.84%
660K
|
n/a
CTM
|
$0.2201
-2.31%
22.67%
48K
|
n/a
VNDA
|
News
|
$5.24
29.38%
22.56%
24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.